Aisling Ross

Aisling Ross is a researcher at the University of Limerick, affiliated with the School of Medicine, Bernal Institute, and Department of Biological Sciences. Her work focuses on nanoparticle properties for drug delivery, cancer biology, and hematological malignancies.

• Key Collaborations: Erasmus University Rotterdam, Technological University of the Shannon

Research Interests center on Nanoparticle Science, Drug Delivery Systems, and Cancer Cell Signaling, with a focus on p53 regulation and Blood-Brain Barrier permeability. Recent studies analyze zeta potential effects on cell viability and nanoparticle toxicity.

Publications highlight interdisciplinary work at the intersection of Nanotechnology and Cancer Therapy, including Mouse Models for cell fate decisions and BH3-Mimetic Drugs targeting TP53 mutations.

• Scientific Awards: Patent Family Citation

Her collaborative network spans institutions like the Bernal Institute and international partners, emphasizing translational applications in Neuropharmacology and Hematological Cancer treatment.